Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Anaemia Resistant to Erythropoietin (PEAR)
2011-006168-30Phase 4Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pentoxifylline in end-stage kidney disease (ESKD) and anaemia, sponsored by Barts Health NHS Trust. Primary endpoint: ESA requirement relative to haemoglobin level. Started Oct 2012; status: terminated.
02
Drugs
pentoxifylline
03
Conditions
end-stage kidney disease (ESKD)anaemia
Beyond the preview
Go deeper on 2011-006168-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006168-30.